Suchergebnisse

Investors in Soleno Therapeutics, Inc. SLNO need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $105 Call had some of the highest

Shares of Soleno Therapeutics SLNO have surged 56.4% over the past week, driven primarily by the announcement that Neurocrine Biosciences NBIX has entered into a definitive agreement with Soleno to

• Shares of Soleno Therapeutics, Inc. (SLNO) surged 32.3% after Neurocrine Biosciences, Inc. (NBIX) agreed to buy the drugmaker for $2.9 billion, or $53 per share in cash.
• Shares of Micron